title: Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?
abstract: A meta-analysis of four trials showed significant advantage in pregnancy and delivery rates with aromatase inhibitors compared with CC in women with PCOS. A recent randomized trial demonstrated no clear benefit.
authors.affiliation: PACMeR (PanHellenic Association for Continual Medical Research), Section of Obstetrics and Gynaecology, Athens, Greece. n.polyzos@gmail.com
authors.forename: Nikolaos P
authors.initials: NP
authors.lastname: Polyzos
authors.forename: Maria
authors.initials: M
authors.lastname: Tsappi
authors.forename: Davide
authors.initials: D
authors.lastname: Mauri
authors.forename: Vedat
authors.initials: V
authors.lastname: Atay
authors.forename: Ivan
authors.initials: I
authors.lastname: Cortinovis
authors.forename: Giovanni
authors.initials: G
authors.lastname: Casazza
mesh_terms: D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology*; D010062:Ovulation Induction / Q000379:methods / Q000639:trends*; D011085:Polycystic Ovary Syndrome / Q000150:complications*; D011247:Pregnancy
chemical_list: D047072:Aromatase Inhibitors